Qvanteq Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 1

Qvanteq General Information


Developer of stent technologies intended to address the effects of coronary artery stents. The company develops a coating-free surface technology to be applied onto the coronary stent or Nitinol-based peripheral stents, which shows endothelialization and thrombogenicity properties, enabling targeted patients to reduce thrombus formation and have fast healing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • Technoparkstrasse 1
  • CH-8005 Zurich
  • Switzerland
+41 044 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qvanteq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Apr-2021 00.000 Completed Generating Revenue
4. Grant 30-Jul-2016 00.000 Completed Generating Revenue
3. Early Stage VC (Series B) 12-Feb-2013 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 27-Apr-2010 $796K $806K 00.000 Completed Generating Revenue
1. Accelerator/Incubator 09-Aug-2009 $9.3K $9.3K Completed Startup
To view Qvanteq’s complete valuation and funding history, request access »

Qvanteq Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 000.00 000.00 00 000.00 00.000
To view Qvanteq’s complete cap table history, request access »

Qvanteq Executive Team (3)

Name Title Board Seat Contact Info
Arik Zucker Co-Founder, Chief Executive Officer & Board Member
Stefano Buzzi Chief Technology Officer
Armin Mäder Ph.D Co-Founder & Chairman
To view Qvanteq’s complete executive team members history, request access »

Qvanteq Board Members (4)

Name Representing Role Since
Arik Zucker Qvanteq Co-Founder, Chief Executive Officer & Board Member 000 0000
Armin Mäder Ph.D Qvanteq Co-Founder & Chairman 000 0000
Hans Tanner Ph.D Self Board Member 000 0000
Suk-Woo Ha Ph.D Self Board Member 000 0000
To view Qvanteq’s complete board members history, request access »

Qvanteq Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qvanteq Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Verve Ventures Venture Capital Minority 000 0000 000000 0
To view Qvanteq’s complete investors history, request access »